Abstract Lipids are an important component of total parenteral nutrition (TPN), contributing the largest caloric load per volume of solution and providing essential fatty acids necessary for survival. However, lipids are known to be causative factors in oxidative stress, which are expressed via the Bcl-2 family of proteins and/or Fas-mediated apoptosis in several tissues. Interestingly, we have recently observed an increase in hepatocyte apoptosis with administration of TPN. To address the mechanism of this apoptosis, we investigated the effects of parenteral lipid administration on apoptotic signaling in a mouse model. C57BL/6J male mice received physiologic saline and standard chow (control) or standard TPN solution with (TPN+L) or without lipid (TPN-L) emulsion. After 7 days of infusion, apoptosis increased in the TPN+L at a significantly higher rate compared with control and TPN-L groups (p <0.05). Both TPN, with and without lipids, suppressed the pro-apoptotic signals Bid and Bcl-xs (p <0.05). In contrast, TPN with lipid increased the expression of Fas and both the pro-apoptotic factor Bad and the anti-apoptotic factor Bcl-xl (p <0.05). These changes may contribute to TPN-induced hepatocyte injury (apoptosis) or suppress the ability of liver hepatocytes to regenerate.
Introduction
Lipids are an important component of total parenteral nutrition (TPN). Fat emulsions are particularly valuable in pediatric TPN because they provide an isotonic solution rich in calories. Clinically, fat-free TPN may rapidly lead to essential fatty acid deficiency. [1, 2, 3, 4, 5] . Therefore, parenteral administration of essential phospholipids, via lipid emulsions, is critical [6] . Additionally, the inclusion of lipid emulsions with TPN prevents hepatic steatosis [7, 8, 9] and is useful for hepatic regeneration after partial hepatectomy [10] .
Despite the need for lipids, lipid administration may have several potential problems. Lipid uptake is known to stimulate macrophages and thereby plays a role in lung tissue inflammation seen in response to long-term lipid-based TPN in pigs [11] . Additionally, TPN-associated cholestasis has been reported to increase significantly in patients administered lipids as part of their TPN regimen [7] . Additionally, lipid emulsions are known to be causative factors in mitochondrial oxidative stress, which is expressed via the Bcl-2 family of proteins and/or Fas-mediated apoptosis in liver tissues [12, 13, 14, 15, 16] . A major intracellular signaling pathway for apoptosis is mediated by the Bcl-2 family of proteins. Members of this family can either function to prevent apoptosis (Bcl-2, Bcl-xl, Bcl-w) or support intracellular apoptotic signaling (Bax, Bak, Bid, Bad, Bcl-xs).
We have recently observed an increase in hepatocyte apoptosis with TPN administration using a mouse model, similar to the increase in intestinal epithelial cell apoptosis and resulting in villus atrophy [17] . However, the mechanism responsible for this increase in hepatocyte apoptosis is not clear. Because lipid administration has been associated with the development of TPNassociated cholestasis [18] , we hypothesized that the observed increase in hepatocyte apoptosis may be due in part to the inclusion of lipids. To address the mechanism of this TPN-associated apoptosis seen in liver tissue, we investigated the expression of various pro-apoptotic and anti-apoptotic factors. We hypothesized that the hepatocyte apoptosis observed with TPN administration would be associated with an increase in pro-apoptotic signals and a concomitant decrease in anti-apoptotic signals, with the effect being greater in the TPN+L group.
Materials and methods

TPN model
C57BL/6J male, 10-12-week-old, specific pathogen-free mice (Jackson Laboratories, Bar Harbor, ME) weighing 23-25 g were housed in metabolic cages and underwent an acclimatization period of 1 week. They were fed standard chow and had access to tap water ad libitum. The mice were maintained in a 12:12-hr day/night rhythm at a constant temperature of 23ºC and a relative humidity of 40-60%. They were anesthetized with 50 mg/kg of sodium pentobarbital intraperitoneally. A silastic rubber catheter (0.012 inch i.d. · 0.025 inch o.d., Konigsberg Instruments, Pasadena, CA) was inserted into the superior vena cava through the left jugular vein, tunneled subcutaneously, and brought out through the skin of the midscapular region with a swivel spring. This set-up allowed the mice freedom of movement in their metabolic cages (Metamount System, Instech, Plymouth Meeting, MA). Catheterized mice were connected to an infusion pump (AIM pain provider pump, donated by Abbott Laboratories, Abbott Park, IL), and saline (dextrose 5% in 0.45% normal saline with 20 mEq KCl/L) was infused at an initial rate of 9.6 ml/day. After 24 h the animals were randomized into the following three groups: The control group received the same intravenous physiologic saline solution at 7 ml/24 h, in addition to standard laboratory mouse chow and water ad libitum. The TPN-treated groups received either standard TPN solution with (TPN+L) or without lipid (TPN-L) emulsion intravenously at 7 ml/24 h with no enteral nutrition. The TPN solution contained a balanced mixture of amino acids and dextrose in addition to electrolytes, trace elements, and vitamins. Caloric delivery was based on caloric intake measurements from previous investigators so that caloric and protein delivery was essentially the same for the three groups. Caloric delivery was compensated by an increased delivery of dextrose. After 7 days of total continuous infusion, blood was collected for liver biochemistry tests, and the mice were sacrificed using CO 2 . Whole liver samples were harvested and sliced into approximately equal quantities and stored at -70°C until examination.
Apoptosis detection
Hepatocyte apoptosis was detected by the TUNEL staining kit according to the manufacturer's instructions (in situ cell death detection (POD) kit, Roche Diagnostic, Penzberg, Germany). Apoptosis was expressed as the number of positive cells per 200 hepatocytes examined using a microscope.
Liver biochemical assays
Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (alk phos), cholesterol, glucose and gamma glutamyltransferase (G-GGT) were measured by standard assay techniques (Ektachem 750 system, Johnson and Johnson, New Brunswick, NJ) using mouse serum, stored at -70°C until assay.
mRNA expression mRNA expression of apoptotic factors was measured by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) techniques. Liver total cellular RNA was obtained using TRIzol Reagent (Gibco BRL, Gaithersburg, MD), according to the manufacturer's instructions, and purified RNA samples were stored at -70°C until examination. Next, 5 lg of RNA was added to an RT mixture (total volume 28 lL) of 5 lL of 10· PCR buffer II (Perkin-Elmer Roche, Foster City, CA), 10lL of 25 mM MgCl 2 (Perkin-Elmer Roche, Foster City, CA), 5lL of 10 mM dNTPs (Roche Molecular Biochemicals, Indianapolis, IN), 1.5lL of 40U RNAase inhibitor (Roche Molecular Biochemical, Indianapolis, IN), 4lL of 50lM Oligo (dT)12-18 (Gibco BRL, Gaithersburg, MD), and 2.5lL of 200U/lL M-MLV reverse transcriptase (Gibco BRL, Gaithersburg, MD). The sample mixtures were incubated at 40ºC for 70 min and at 95ºC for 3 min and stored at 4ºC until the polymerase chain reaction {PCR). The PCR mixture contained 1 lL each of 5 lM primer pair [17] , 0.8 lL of 10· PCR buffer, 0.2 lL of 25 mM MgCl2, and 0.1 lL of 5 IU/lL Ampli Taq DNA polymerase (Perkin-Elmer Roche, Foster City, CA), with sufficient DEPC-treated water to bring the mixture to a total volume of 6 lL. Primer pairs were designed with an optimization program (Oligo 4.1, National Biosciences, Plymouth, MN) and were based on the GeneBank accession number [17] for the appropriate mouse mRNA sequence. Thermocycler settings were 94ºC for 15 s, 55ºC for 15 s, and 72ºC for 1 min for each primer pair. To ensure that the DNA product was examined at the exponential portion of the PCR curve, the following number of cycles was used for each mRNA: 26 cycles for Fas, Fas-L, Bad, Bax and Bcl-xl; 35 cycles for bak, Bcl-xs, Bid, Bcl-w, Bak and Bcl-2. b-actin expression (equal number of PCR cycles to the respective transporter gene) was also generated for each sample as a control. The PCR products were applied to a 2% agarose gel for 1 h at 160 volts. PCR products were imaged, and results are expressed relative to the expression of bactin.
Statistical analysis
Results are expressed as the mean ± SD. Data analysis was performed using unpaired t -tests and one-way analysis of variance, with p <0.05 considered significant. Post-hoc intergroup analysis was performed using Bonferroni t -tests.
Results
Physiologic changes in the mouse
The TPN+L group had a lower 7-day survival rate (71%) compared with the control group (100%) and the TPN-L group (83%). Liver wet weight was the same in both TPN groups (0.8±0.1 g) and was significantly decreased compared with the control group (1.3±0.2 g; p <0.05). Serum biochemical parameters are shown in Table 1 . In the TPN+L group, AST levels (640±252 U/ L, p <0.05) were increased significantly compared with controls (139±50 U/L) and TPN-L groups (130±54 U/ L; p <0.05). Other laboratory values of note consisted of an elevated glucose level in the TPN-L group but normal cholesterol and G-GTP levels in all groups (Table 1) .
Hepatocyte apoptosis
Hepatocyte apoptosis, expressed as a ratio of positive cells per 200 hepatocytes using TUNEL staining, was relatively infrequent in all histologic specimens. How-ever, there was a significant and almost two-fold increase in hepatocyte apoptosis in the TPN+L group (0.56±0.03) compared with both control (0.24±0.06) and TPN-L groups (0.35±0.07; p <0.05) (Fig. 1) .
To help identify the potential mechanisms involved in the development of this increased hepatocyte apoptosis, we then examined the expression of a number of factors responsible for mediating hepatocyte apoptosis.
mRNA expression of Fas/ Fas-L mRNA expression
Fas mRNA expression significantly increased 1.5 times in the TPN+L group (2.30±0.27, p <0.05) compared with the control (1.75±0.11) and TPN-L groups (1.52±0.16). Fas-L mRNA expression was not significantly different among any of the groups studied (Fig. 2) . mRNA expression of pro-apoptotic factors of the Bcl-2 protein family
The expression of the pro-apoptotic factor Bid significantly decreased in both TPN groups (TPN-L, 0.37±0.15; TPN+L, 0.46±0.20) compared with the control group (0.71±0.29; p <0.05) (Table 2, Fig. 2) . The expression of the pro-apoptotic factor Bcl-xs also significantly decreased in both TPN groups (TPN-L, 0.74±0.22; TPN+L, 0.77±0.11) compared with the control group (1.18±0.40; p <0.05). In contrast, the pro-apoptotic factor Bad significantly increased in the TPN+L group (0.79±0.24) compared with both the control (0.16±0.06) and the TPN-L groups (0.22±0.05; p <0.05).
mRNA expression of anti-apoptotic factors of the Bcl-2 protein family
The expression of the anti-apoptotic factor Bcl-xl significantly increased in the TPN+L group (0.46±0.08) compared with both the control group (0.26±0.08) and the TPN-L group (0.29±0.04; p <0.05). Bcl-w expression did not change following treatment in any of the groups. Although Bcl-2 is typically a strong anti-apoptotic factor, it is not normally expressed in hepatocytes, and we did not detect appreciable levels in our experiments (Fig. 3) . 
Discussion
It is known that lipid emulsions suppress the chemotactic function of monocytes in the presence of severe sepsis. Thus, the infusion of fat emulsions may lead to a further deterioration of immunologic function in septic individuals or in those at risk for infection [19, 20] . In our study, the TPN+L group had a lower 7-day survival rate compared with the survival rates of the control and TPN-L groups. Recently, lipid emulsions have been shown to be causative factors in mitochondrial oxidative stress as manifested by increased rates of apoptosis [12, 13, 14, 15, 16] . Morphological liver examination in our TPN+L models demonstrated increased apoptosis. A major intracellular signaling pathway for apoptosis is known to be mediated by the Bcl-2 family of proteins. Pro-apoptotic proteins of the Bcl-2 family act on mitochondria and facilitate the release of cytochrome c [12, 13, 15, 21] . In our models, the expression of Bid significantly decreased in both TPN groups in spite of increased Fas expression. Fas stimulation results in normal activation of caspase-3, which has been reported to be arrested in Bid-deficient mice [22] . Esposti et al. suggest that some pro-apoptotic proteins including Bid have an intrinsic capacity of binding and exchanging lipids and lysolipids with mitochondrial membranes [22] . Administration of TPN with lipids might lead to disruption of the signal in normal liver tissue, causing a dysfunction in the lipid exchange within mitochondrial membranes. Our TPN models may have inactivated Bid signals, resulting in non-stimulation of the Fas-caspase pathway. The mitochondrial signal pathway is known to closely correlate with cell cycle arrest, cell apoptosis, and/or cell death. We have previously reported that administration of TPN with lipids results in an arrest of the hepatocyte cell cycle (unpublished data). While the serum lipid pattern of livers exposed to TPN with lipids is normal, the phospholipid fraction contains an abnormal fatty acid pattern consistent with the development of essential fatty acid deficiency [23] . The exact physiologic significance of this is unknown, but it is tempting to speculate that changes in integrity of the hepatic cell membrane as a result of this abnormal fatty acid pattern might account for some of the clinical abnormalities of hepatic function seen during TPN administration [23] . The pro-apoptotic factor (Bad) and anti-apoptotic factor (Bcl-xl) were significantly increased in the TPN+L group. The activation of Bad has been reported to promote the suppression of anti-apoptotic signals by binding to Bcl-xl or Bcl-2. It is known that the role of Bcl-xl is that of an anti-inflammatory mediator in macrophages and immature CD4+CD8+ thymocytes [24, 25] . In our model, the Bcl-xl expression might correlate with increasing macrophage activity after the administration of lipids in TPN models, because the lipid emulsion is known to lead to the suppression of immunologic function [1, 2, 3, 4, 5] . Further investigation of this problem is warranted. In addition to the lipids themselves, other contaminating factors could also play an essential role. The potential etiology of these changes may also be due to the associated phytosterols that are present in most commercial lipids and that have been suggested to contribute to the development of TPN-associated cholestasis [18] .
In conclusion, TPN, both with and without lipids, suppressed the pro-apoptotic signals Bid and Bcl-xs in a mouse model. TPN administration might lead to liver dysfunction by interrupting such cell signal pathways. TPN with lipids activated Fas, the pro-apoptotic factor Bad, and the anti-apoptotic factor Bcl-xl, and induced histological apoptosis. These changes may also contribute to TPN-induced hepatocyte injury (apoptosis) or suppress the ability of liver hepatocytes to regenerate. We hope that future work will direct the use of safer Table 2 mRNA expression of pro-and anti-apoptotic factors of the Bcl-2 protein family (data presented as mean ± SD). Results of hepatocyte apoptosis (see Fig. 1 compared with TPN-L group; p<0.05, using ANOVA with post-hoc analysis between groups Fig. 3 mRNA expression of anti-apoptotic factors of the Bcl-2 protein family. The anti-apoptotic factor Bcl-xl significantly increased in the TPN+L group. * p <.05
TPN solutions that will have fewer deleterious effects on hepatocytes.
